Sunday, July 12, 2026 Never miss a recall or a rule change Go Pro · $20/mo →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
1 free article left this week. A free account gets you 4 a week.Go Pro →
Devices & Tech

Hugel's Toxin Manufacturing Scales to 25,000 Vials From a Thumb-Sized Tube — Supply Chain Efficiency

South Korean manufacturer demonstrates production scale; implications for global neuromodulator supply.

Image: Inside MedSpa

Hugel, the South Korean biopharmaceutical company behind Botulax (a botulinum toxin approved in multiple markets outside the U.S.), has detailed its manufacturing process, which yields approximately 25,000 toxin vials from a single thumb-sized production tube. The efficiency reflects advances in fermentation, purification, and fill-finish processes that have matured over decades of toxin production.

Hugel's manufacturing process yields 25,000 toxin vials from a single production tube.

While Hugel's products are not yet FDA-approved for the U.S. market, the company's manufacturing prowess underscores the global capacity for botulinum toxin production and the potential for new entrants to challenge Allergan's and Evolus' market share if regulatory pathways open. For U.S. practices, this signals that supply constraints are not a structural barrier to new competitors; the bottleneck is regulatory approval and market access. As relabotulinum (Galderma) and other candidates move through FDA review, manufacturing scale is not a limiting factor. The real competition will be on clinical differentiation, onset/duration profiles, and rebate aggressiveness.

Source: original report ↗

Free alerts

Free: recall & rule-change alerts for your practice.

Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.

Free · weekly · unsubscribe anytime. Privacy.

Stay three moves ahead of every practice in your market.

Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.

Get the edge · $20/mo

Join the owners who run ahead of the industry. Cancel anytime, one click.

Discussion

    Leave a comment

    Comments are reviewed before they appear.
    Inside MedSpa Pro

    By the time it's news, it's too late.

    The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

    Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.
    The twice-a-week intelligence brief Go Pro · $20/mo